Abstract:Objective To evaluate the efficacy and safety of prucalopride two mg once daily in the treatment of chronic constipation (CC) in China.Methods In this multicentre,randomised,placebo controlled,parallel-group,phase Ⅲ study,patients with CC received either two mg prucalopride or placebo,once daily,for 12 weeks.The primary efficacy endpoint was the proportion of patients reaching an average of three or more spontaneous complete bowel movements (SCBM) per week during the 12 week treatment.The key secondary efficacy endpoint was the percentage of patients reaching three or more SCBM/week during the first four weeks of treatment.Other efficacy assessments included the average number of SCBM/week; the median time to onset of first SCBM after intake of the first dose of trial medication and the average number of bisacodyl tablets or enemas used per week.Furthermore,the symptoms of constipation were assessed by patient assessment of constipation symptom (PAC-SYM) questionnaire.The quality of life was evaluated by patient assessment of constipation-quality of life (PAC-QOL) questionnaire.Safety assessments included adverse events,laboratory values and cardiovascular events.Results Four hundred and forty-six patients from China were screened,313 were treated and 295 completed 12-week study treatment.Averaged over 12 weeks,significantly higher proportion of patients on prucalopride two mg (39.4％,P＜0.01) had three or more SCBM/week compared with placebo (12.7％,x2 =29.50,P＜0.01).Over four weeks,significantly higher proportion of responders was also found in patients on prucalopride (40.0 ％vs 13.3 ％,x2 =28.58,P＜0.01).Prucalopride also significantly improved associated symptoms and quality of life (QOL).The most frequent treatment emergent adverse events were diarrhoea,nausea,abdominal pain,and headache,which were mild to moderate and transient,spontaneously resolved in a few days.Conclusion Prucalopride two mg once daily significantly improved bowel function,associated symptoms and satisfaction in CC over a 12-week treatment period,and was safe and well tolerated in Chinese patients.

Can prucalopride improve the efficacy and tolerability of colonoscopy preparation ?

Oral sulfate solution versus polyethylene glycol for colonoscopy bowel preparation: a randomized controlled study in phase Ⅲ

Effect of prucalopride to improve time to gut function recovery following elective colorectal surgery: randomized clinical trial

The Advantage of Polyethylene Glycol Electrolyte Solution Combined with Lactulose in Patients with Long Interval Preparation-to-colonoscopy.

Antiemetics Improve the Tolerance of Polyethylene Glycol for Colonoscopy Preparation A Randomized Clinical Trial

Comparison of Two Litre Polyethylene Glycol Plus Bisacodyl Versus Four Litre Polyethylene Glycol As Preparation for Colonoscopy in Colon Disease: a Systemic Review and Meta-Analysis

Combined Use of Mosapride and Polyethylene Glycol for Colonoscopy Preparation

Bowel Preparation Efficacy and Discomfort of 2 L Polyethylene Glycol Combined with Linaclotide Versus 3 L Polyethylene Glycol: a Noninferiority, Prospective, Multicenter, Randomized Controlled Trial

Efficacy of Linaclotide in Combination with Polyethylene Glycol for Bowel Preparation in Chinese Patients Undergoing Colonoscopy Polypectomy: Protocol for a Randomised Controlled Trial.

High-resolution manometry reveals different effect of polyethylene glycol, bisacodyl, and prucalopride on colonic motility in healthy subjects: An acute, open label, randomized, crossover, reader-blinded study with potential clinical implications

Prucalopride in the Treatment of Chinese Patients with Chronic Constipation: a Randomised, Double-Blind,placebo-controlled Study

Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study.

Application of linaclotide in bowel preparation for colonoscopy in patients with constipation: A prospective randomized controlled study

Comparison of the efficacy and safety of an oral sulfate solution and 3-liter polyethylene glycol on bowel preparation before colonoscopy: a phase III multicenter randomized controlled trial

Comparative Efficacy of Combination of 1 L Polyethylene Glycol, Castor Oil and Ascorbic Acid Versus 2 L Polyethylene Glycol Plus Castor Oil Versus 3 L Polyethylene Glycol for Colon Cleansing Before Colonoscopy

Role of Itopride in the Improvement of Bowel Preparation Before Colon Endoscopy Examination in Constipated Patients

Clinical outcomes before and after prucalopride treatment: an observational study in patients with chronic idiopathic constipation in the USA

Efficacy of Polyethylene Glycol Electrolyte Powder Combined with Linaclotide for Colon Cleansing in Patients with Chronic Constipation undergoing colonoscopy: a Multi-centre, single-blinded, Randomized-Controlled Trial.

Exploration of an Improved Bowel Preparation for Inflammatory Bowel Disease Patients

Polyethylene glycol combined with lactulose has better efficacy than polyethylene glycol alone in bowel preparation before colonoscopy: A meta-analysis

Randomized clinical trial of a split-dose bowel preparation with 2L polyethylene glycol plus castor oil versus 1L polyethylene glycol plus castor oil and ascorbic acid before colonoscopy